SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana (CVNA) is trending with high volatility after its earnings report missed adjusted profit estimates despite record revenue, fueling intense community debate around its business model, heavy reliance on loan sales, and perceived accounting practices amid a lack of clear forward guidance.

DoorDash, Inc. engages in the design, development, and operation of a food delivery and logistics platform. It serves consumers in the United States, Canada, and Australia. The company was founded by Andy Fang, Tony Xu, Stanley Tang, and Evan Moore on January 12, 2013 and is headquartered in San Francisco, CA.

DoorDash Inc - Ordinary Shares - Class A

DoorDash surged after-hours, driven by an optimistic Q1 marketplace GOV outlook that overshadowed a Q4 earnings and revenue miss, leading to a fierce debate among investors about its current valuation and future growth trajectory.

Remitly Global, Inc. engages in the provision of digital financial services for immigrants and their families. The company was founded by Matthew B. Oppenheimer and Joshua Hug on October 3, 2018 and is headquartered in Seattle, WA.

Remitly Global Inc

Remitly Global is trending strongly after delivering better-than-expected Q4 and full-year results, achieving its first full year of GAAP profitability, and providing robust 2026 guidance, driving significant community excitement and trading volume around its growth narrative and strategic advancements in AI and stablecoins.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as geopolitical concerns regarding Iran escalate and the Federal Reserve sends mixed signals on interest rates, fueling intense community debate over potential market manipulation while dip-buying bulls continue to challenge bearish reversal predictions.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following better-than-expected earnings and robust forward-looking projections, sparking intense community debate over whether AI will augment its platform or continue to challenge the software sector, drawing attention from both new investors and those anticipating a short squeeze.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

AIRCOIN is trending as its strong community actively locks over 40% of the supply through the AirLock mechanism, generating significant discussion around enhanced supply control and its position as a trustworthy Solana meme coin with aspirations for widespread exchange listings.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending due to a significant and sustained downturn, reaching new 52-week lows amidst investor frustration and confusion. The community is actively debating whether the stock has found a bottom, pointing to recent leadership changes, a weaker outlook, and broader macroeconomic concerns affecting pet spending, all while anticipating the upcoming March earnings report for a potential catalyst.

Booking Holdings, Inc. engages in the provision of online travel and related solutions. The firm offers services through the following brands: Booking.com, Priceline, Agoda, KAYAK, and OpenTable. It provides accommodation reservations including hotels, hostels, apartments, vacation rentals, and other properties. The company was founded by Jay Scott Walker on July 18, 1997, and is headquartered in Norwalk, CT.

Booking Holdings Inc

Booking Holdings is trending due to its strong Q4 earnings beat, optimistic 2026 guidance, and an announced 25-for-1 stock split coupled with a dividend hike. The community is largely bullish on this comprehensive positive news, though some express reservations about historical stock split performance and potential competitive impacts from AI.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

The community is actively discussing Zevra Therapeutics following a recent court ruling granting partial summary judgment against the company in a key licensing dispute, with the potential for substantial financial remedies. This legal development, alongside a new board appointment with M&A experience and a CFO departure, is fueling significant speculation among investors about a potential near-term acquisition, even as Miplyffa expands its global access through new distribution agreements.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as major hyperscalers like Amazon and Google announce unprecedented capital expenditures for AI infrastructure, with analysts and the community highlighting AVGO's crucial role in supplying custom AI accelerators and networking solutions. While some express frustration over short-term volatility and perceived manipulation, broader sentiment remains highly bullish on its foundational position in the ongoing AI build-out ahead of upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up - Here's Why

Jade Biosciences (NASDAQ:JBIO) Shares Gap Up - Should You Buy...

Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totaling 1,345,619 shares, a decrease of...

Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3% - Here's What Happened

Jade Biosciences (NASDAQ:JBIO) Trading Down 5.3% - Should You Sell...

Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9%

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totaling 1,546,739 shares, an...

Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages

Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six analysts that are covering the firm, Marketbeat reports. One analyst has...

Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8% - Should You Sell?

Jade Biosciences (NASDAQ:JBIO) Shares Down 4.8% - Time to Sell...

Jade Biosciences (NASDAQ:JBIO) Shares Gap Down - Time to Sell?

Jade Biosciences (NASDAQ:JBIO) Shares Gap Down - Time to Sell...

Jade Biosciences (NASDAQ:JBIO) Trading Down 3.7% - Here's Why

Jade Biosciences (NASDAQ:JBIO) Shares Down 3.7% - What's Next...

Jade Biosciences (NASDAQ:JBIO) Stock Price Up 4.5% - Here's What Happened

Jade Biosciences (NASDAQ:JBIO) Trading Up 4.5% - Here's What Happened...

Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Jade Biosciences, Inc. (NASDAQ:JBIO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five research firms that are covering the stock, Marketbeat Ratings...

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Jade Biosciences Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $WMT earnings on Thursday?

JBIO
Jade Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JBIO News

JBIOJade Biosciences Inc